CrushSCI.com
133.2平均天数
133中位天数
2最短天数
345最长天数
3622025发文量

Paper Review Records

全部论文审稿周期

30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

42 天

Clinical Image: B cell lymphoma mimicking myositis

作者
Mariana Manoel Oku; Joanna C Dalland; Aikaterini Thanou; Margherita Milone展开收起
作者单位
1. Department of Neurology Mayo Clinic Rochester Minnesota; 2. Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota; 3. University of Oklahoma College of Medicine Oklahoma City Oklahoma展开收起
PDF源文件 DOI 网页
41 天

Durable and Additive Disease Control at 52 Weeks With Ixekizumab Plus Tirzepatide Versus Ixekizumab Alone in Adults With Psoriatic Arthritis and Obesity or Overweight: Additional Results From a Randomized Clinical Trial

作者
Joseph F. Merola; Cynthia E. Kartman; Peter Fischer; Philip Mease; Alan Kivitz; Naveed Sattar; Laura C. Coates; Daniel Aletaha; Luna Sun; Yurong Chen; Ketan Marulkar; Natalia Bello; Anabela Cardoso; Mark C. Genovese; Alexis Ogdie展开收起
作者单位
1. Departments of Dermatology and Medicine, Division of Rheumatology, and O'Donnell School of Public Health University of Texas Southwestern Medical Center Dallas; 2. Eli Lilly and Company Indianapolis Indiana; 3. Providence Swedish Medical Center and University of Washington Seattle; 4. Altoona Center for Clinical Research Duncansville Pennsylvania; 5. School of Cardiovascular and Metabolic Health University of Glasgow Glasgow United Kingdom; 6. Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences University of Oxford Oxford United Kingdom; 7. Division of Rheumatology, Department of Internal Medicine III Medical University of Vienna Vienna Austria; 8. Perelman School of Medicine University of Pennsylvania Philadelphia展开收起
PDF源文件 DOI 网页
186 天

Initial Treatment Strategies and Outcomes Across Hemodynamic Thresholds and Risk Stratification in Incident Systemic Sclerosis–Associated Pulmonary Arterial Hypertension: A EUSTAR Analysis

作者
Hilde Jenssen Bjørkekjær; Cosimo Bruni; Kaspar Broch; Cathrine Brunborg; Patricia E. Carreira; Paolo Airò; Carmen Pilar Simeón‐Aznar; Marie‐Elise Truchetet; Alessandro Giollo; Alexandra Balbir‐Gurman; Mickael Martin; Christopher P. Denton; Armando Gabrielli; Francesco Del Galdo; Madelon C. Vonk; Håvard Fretheim; Helle Bitter; Øyvind Midtvedt; Arne K. Andreassen; Sverre Høie; Yoshiya Tanaka; Gabriela Riemekasten; Ulf Müller‐Ladner; Marco Matucci‐Cerinic; Ivan Castellví; Elise Siegert; Eric Hachulla; Øyvind Molberg; Oliver Distler; Anna‐Maria Hoffmann‐Vold; the European Scleroderma Trials and Research (EUSTAR) collaborators展开收起
作者单位
1. Department of Rheumatology Hospital of Southern Norway Kristiansand Norway; 2. Institute of Clinical Medicine University of Oslo Oslo Norway; 3. Department of Rheumatology University Hospital Zurich, University of Zurich Zurich Switzerland; 4. Department of Cardiology Oslo University Hospital, Rikshospitalet Oslo Norway; 5. Institute for Experimental Medical Research, KG Jebsen Center University of Oslo Oslo Norway; 6. Oslo Centre for Biostatistics and Epidemiology, Research Support Services Oslo University Hospital, Rikshospitalet Oslo Norway; 7. Department of Rheumatology University Hospital 12 de Octubre Madrid Spain; 8. Scleroderma Unit UOC Reumatologia ed Immunologia Clinica, Spedali Civili di Brescia Brescia Italy; 9. Systemic Autoimmune Diseases Unit, Department of Internal Medicine University Vall d'Hebron Hospital Barcelona Spain; 10. Rheumatology Department Bordeaux University Hospital Bordeaux France; 11. Rheumatology Unit, Department of Medicine University of Verona Verona Italy; 12. Rheumatology Unit, Department of Medicine – DIMED Padua University Hospital Padova Italy; 13. Rheumatology Institute, Rambam Health Care Campus, Rappaport Faculty of Medicine Technion – Institute of Technology Haifa Israel; 14. Department of Internal Medicine Poitiers University Hospital Poitiers France; 15. Royal Free Hospital, Centre for Rheumatology and Connective Tissue Diseases, Division of Medicine University College London London United Kingdom; 16. Fondazione di Medicina Molecolare e Terapia Cellulare Università Politecnica delle Marche Ancona Italy; 17. Hiller Research Center University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf Germany; 18. Leeds Institute of Rheumatic and Musculoskeletal Medicine Leeds United Kingdom; 19. Leeds Biomedical Research Centre, National Institute for Health and Care Research Leeds Teaching Hospitals Trust Leeds United Kingdom; 20. Department of Rheumatology Radboud Universiteit Nijmegen the Netherlands; 21. Lillehammer Hospital for Rheumatic Diseases Lillehammer Norway; 22. Department of Rheumatology Oslo University Hospital, Rikshospitalet Oslo Norway; 23. Department of Cardiology Hospital of Southern Norway Arendal Norway; 24. ProCardio Center for Innovation, Clinic of Heart, Lung and Vascular Diseases Oslo University Hospital, Rikshospitalet Oslo Norway; 25. First Department of Internal Medicine University of Occupational and Environmental Health Kitakyushu Japan; 26. Department of Rheumatology and Clinical Immunology University of Lübeck Lübeck Germany; 27. Department of Rheumatology and Clinical Immunology Justus‐Liebig University Giessen, Campus Kerckhoff Bad Nauheim Germany; 28. Unit of Immunology, Rheumatology, Allergy and Rare Diseases, Inflammation, Fibrosis and Ageing Initiative IRCCS San Raffaele Hospital Milan Italy; 29. University Vita Salute San Raffaele Milan Italy; 30. Inflammation, Fibrosis and Ageing Initiative, Division of Genetics and Cell Biology IRCCS San Raffaele Scientific Institute Milan Italy; 31. Department of Rheumatology, Institut de Recerca Sant Pau Hospital de la Santa Creu i Sant Pau Barcelona Spain; 32. Rheumatology Charité University Hospital Berlin Germany; 33. Department of Internal Medicine and Clinical Immunology, Referral Centre for Rare Systemic Autoimmune Diseases North of France, North‐West, Mediterranean and Guadeloupe Centre Hospitalier Universitaire de Lille, Inserm, U1286 Lille France; 34. Institute for Translational Research in Inflammation Lille France展开收起
PDF源文件 DOI 网页
195 天

Differentiation and Pathologic Significance of Tissue‐Resident Memory‐Like CD8 + T Cells in Systemic Lupus Erythematosus

作者
Yuya Fujita; Kaoru Yamagata; Satoshi Kubo; Ippei Miyagawa; Koshiro Sonomoto; Yurie Satoh‐Kanda; Masanobu Ueno; Shumpei Kosaka; Aya Nawata; Yoshiya Tanaka; Shingo Nakayamada展开收起
作者单位
1. The First Department of Internal Medicine School of Medicine, University of Occupational and Environmental Health Kitakyushu Japan; 2. Department of Molecular Targeted Therapies School of Medicine, University of Occupational and Environmental Health Kitakyushu Japan; 3. Department of Clinical Nursing School of Health Sciences, University of Occupational and Environmental Health Kitakyushu Japan; 4. Department of Pathology and Oncology University of Occupational and Environmental Health Kitakyushu Japan展开收起
PDF源文件 DOI 网页
212 天

Cluster analysis identifies anti‐synthetase syndrome as a distinct and heterogeneous clinical entity: Analysis from the Classification Criteria for Anti‐Synthetase Syndrome project database

作者
Akira Yoshida; Iazsmin Bauer Ventura; Eduardo Dourado; Giovanni Zanframundo; Sara Faghihi‐Kashani; Aravinthan Loganathan; Daphne Rivero Gallegos; Francisca Bozan; Gianluca Sambataro; Sangmee Sharon Bae; Laure Gallay; Albert Selva‐O'Callaghan; Andrew L. Mammen; Carlomaurizio Montecucco; Chester V. Oddis; David F. Fiorentino; Francesco Bonella; Frederick W. Miller; Ingrid E. Lundberg; Jorge Rojas‐Serrano; Masataka Kuwana; Miguel Angel González‐Gay; Neil McHugh; Tamera J. Corte; Tracy Jennifer Doyle; Vega Jovani; Linda Carli; Pier Paolo Sainaghi; Natsuka Umezawa; Merrilee Needham; Giovanni Cagnotto; Nair Perez‐Gómez; Paola Tomietto; Massimiliano Limonta; Maria Giovanna Danieli; Antonella Notarnicola; José Cifrian‐Martinez; Julia Martinez‐Barrio; Helena Andersson; Yasuhiro Kondoh; Reinhard Edmund Voll; Stylianos Tomaras; Pari Basharat; Farah Tamirou; Paola Parronchi; Matthias Schneider; the CLASS project participating investigators; Lorenzo Cavagna; Rohit Aggarwal展开收起
作者单位
1. Department of Allergy and Rheumatology Nippon Medical School Graduate School of Medicine Tokyo Japan; 2. Section of Rheumatology, Department of Medicine University of Chicago Chicago IL USA; 3. Rheumatology Department, Unidade Local de Saúde da Região de Aveiro Aveiro Portugal; 4. Aveiro Rheumatology Research Centre, Egas Moniz Health Alliance Aveiro Portugal; 5. Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa Lisbon Portugal; 6. Department of Internal Medicine and Therapeutics, Università di Pavia Pavia Italy; 7. Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo Pavia Italy; 8. Division of Rheumatology and Clinical Immunology University of Pittsburgh School of Medicine Pittsburgh PA USA; 9. Royal National Hospital for Rheumatic Diseases Bath UK; 10. Department of Life Sciences University of Bath Bath UK; 11. Arthritis Australia, Broadway, Glebe NSW Australia; 12. Interstitial Lung Disease and Rheumatology Units, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas Mexico City Mexico; 13. Section of Rheumatology, Department of Medicine, Hospital Clínico Universidad de Chile Santiago Chile; 14. Regional Referral Center for Rare Lung Disease, Policlinico "G. Rodolico‐San Marco" University of Catania Catania Italy; 15. Division of Rheumatology, Department of Medicine, David Geffen School of Medicine University of California Los Angeles Los Angeles CA USA; 16. Department of Clinical Immunology, Hôpital Édouard Herriot Lyon France; 17. Systemic Autoimmune Diseases Unit, Internal Medicine Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona Barcelona Spain; 18. National Institute of Arthritis and Musculoskeletal and Skin Disorders, National Institutes of Health Bethesda MD USA; 19. Department of Neurology Johns Hopkins University School of Medicine Baltimore MD USA; 20. Department of Dermatology Stanford University School of Medicine Redwood City CA USA; 21. Center for interstitial and rare lung diseases, Pneumology Department, Ruhrlandklinik University Hospital University of Duisburg‐Essen Essen Germany; 22. Environmental Autoimmunity Group, Clinical Research Branch National Institute of Environmental Health Sciences, National Institutes of Health Durham NC USA; 23. Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet Stockholm Sweden; 24. Division of Rheumatology, IIS‐Fundación Jiménez Díaz Madrid Spain; 25. Medicine and Psychiatry Department University of Cantabria Santander Spain; 26. Department of Respiratory Medicine, Royal Prince Alfred Hospital University of Sydney Sydney Australia; 27. Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital Boston MA USA; 28. Department of Rheumatology, Hospital General Universitario Dr. Balmis, ISABIAL Alicante Spain; 29. Rheumatology Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliero‐Universitaria Pisana Pisa Italy; 30. Department of Translational Medicine and CAAD (Center for Allergic and Autoimmune Diseases), Università del Piemonte Orientale UPO Novara Italy; 31. Rheumatology and Internal Medicine Division, Azienda Ospedaliero Universitaria Maggiore della Carità di Novara Novara Italy; 32. Department of Rheumatology, Graduate School of Medical and Dental Sciences Institute of Science Tokyo Tokyo Japan; 33. Neuromuscular Clinic Perron Institute for Neurological and Translational Science, QEII Medical Centre Nedlands Western Australia Australia; 34. Department of Neurology, Fiona Stanley Hospital Perth Western Australia Australia; 35. Institute for Immunology and Infectious Diseases Murdoch University Perth Western Australia Australia; 36. School of Medicine University of Notre Dame Perth Western Australia Australia; 37. Rheumatology, Clinical Sciences Malmö Lund University Malmö Sweden; 38. UGC de Reumatología, Complejo Hospitalario Universitario de Vigo Vigo Spain; 39. Internal Medicine Department, Rheumatology Unit, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste Italy; 40. Rheumatology, ASST Papa Giovanni XXIII Bergamo Italy; 41. Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Torrette di Ancona Italy; 42. SOS Immunologia delle Malattie Rare e dei Trapianti, Clinica Medica, AOU delle Marche, Torrette di Ancona Italy; 43. Department of Pulmonology, Hospital Universitario Marqués de Valdecilla, Av Valdecilla SN Santander Spain; 44. Instituto de Investigación Biomédica de Cantabria (IDIVAL), Santander Spain; 45. University of Cantabria Santander Spain; 46. Department of Rheumatology, Hospital Universitario Gregorio Marañón Madrid Spain; 47. Department of Rheumatology Oslo University Hospital Oslo Norway; 48. Department of Respiratory Medicine and Allergology Aichi Medical University Nagakute Japan; 49. Department of Rheumatology and Clinical Immunology Medical Center ‐ University of Freiburg, Faculty of Medicine, University of Freiburg Freiburg Germany; 50. Department of Rheumatology, Helios Clinic Vogelsang‐Gommern Gommern Germany; 51. Department of Medicine, Division of Rheumatology, London Health Sciences Centre, Schulich School of Medicine & Dentistry University of Western Ontario London ON Canada; 52. Department of Rheumatology, Cliniques Universitaires Saint‐Luc, Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, UCLouvain Brussels Belgium; 53. Department of Experimental and Clinical Medicine University of Florence Florence Italy; 54. Department of Rheumatology, Heinrich‐Heine University Düsseldorf Germany; 55. Hiller Research Center for Rheumatology, Heinrich‐Heine University Düsseldorf Germany展开收起
PDF源文件 DOI 网页
134 天

The Association Between Systemic Inflammation as Measured by Calprotectin and Autoantibody Load in Rheumatoid Arthritis

作者
Caroline Grönwall; Linda Mathsson Alm; Helga Westerlind; Isabel Gehring; Nasim Ghasemzadeh; Niels Steen Krogh; Siri Lillegraven; Espen Haavardsholm; Martina Johannesson; Tore K. Kvien; Johan Rönnelid; Tue Wenzel Kragstrup; Bente Glintborg; Merete Lund Hetland; Hilde Berner Hammer; Danish Rheumatologic Biobank Study Group; Swedish Rheumatology Quality Register Biobank Study Group; Johan Askling展开收起
作者单位
1. Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet Karolinska University Hospital, Center for Molecular Medicine Stockholm Sweden; 2. Thermo Fisher Scientific Uppsala Sweden; 3. Department of Immunology, Genetics and Pathology Uppsala University Uppsala Sweden; 4. Clinical Epidemiology Division, Department of Medicine Solna Karolinska Institutet Stockholm Sweden; 5. Thermo Fisher Scientific Freiburg Germany; 6. ZiteLab ApS Frederiksberg Denmark; 7. Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY) Diakonhjemmet Hospital Oslo Norway; 8. Faculty of Medicine University of Oslo Oslo Norway; 9. Department of Biomedicine Aarhus University Aarhus Denmark; 10. Department of Rheumatology Silkeborg Regional Hospital Silkeborg Denmark; 11. Department of Molecular Medicine Aarhus University Hospital Aarhus Denmark; 12. Department of Clinical Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark; 13. DANBIO, The Danish Rheumatologic Biobank, and Copenhagen Center for Arthritis Research (COPECARE) Center for Rheumatology and Spine Diseases Rigshospitalet Glostrup Denmark展开收起
PDF源文件 DOI 网页

FAQ

Arthritis & Rheumatology审稿要多久?

截至2026-11-17,CrushSCI 收录了 Arthritis & Rheumatology 的 30 篇完整审稿记录。最快一篇从收稿到录用用了 2 天(Dermatomyositis in skin of color population: expanding clinical recognition,2026-06-16 收稿,2026-06-18 录用),最慢一篇用了 345 天;平均 133.2 天,中位数 133 天。最快这篇的日期间隔异常短,建议点开原文核对。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。